Brief: Lipigon Pharmaceuticals Carries Out Directed Issue Of Shares To Underwriters
04/06/2025 13:47
June 4 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: CARRIES OUT DIRECTED ISSUE OF SHARES TO UNDERWRITERS SUBSCRIPTION PRICE IN COMPENSATION ISSUE IS SET AT SEK 0.09 PER SHARE Source text: ID:nBQN5W0bzw Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds